Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Perrone, Francesco"'
Autor:
Chu, Quincy1 (AUTHOR), Perrone, Francesco1,2 (AUTHOR), Greillier, Laurent1,3,4,5,6,7,8 (AUTHOR), Tu, Wei1,9 (AUTHOR), Piccirillo, Maria Carmela2 (AUTHOR), Grosso, Federica10 (AUTHOR), Lo Russo, Giuseppe11 (AUTHOR), Florescu, Marie12 (AUTHOR), Mencoboni, Manlio13 (AUTHOR), Morabito, Alessandro14 (AUTHOR), Cecere, Fabiana Letizia15 (AUTHOR), Ceresoli, Giovanni Luca16 (AUTHOR), Dawe, David E17 (AUTHOR), Zucali, Paolo Andrea18,19 (AUTHOR), Pagano, Maria20 (AUTHOR), Goffin, John R21 (AUTHOR), Sanchez, Myriam Locatelli22 (AUTHOR), Gridelli, Cesare23 (AUTHOR), Zalcman, Gerard24 (AUTHOR), Quantin, Xavier25 (AUTHOR)
Publikováno v:
Lancet. Dec2023, Vol. 402 Issue 10419, p2295-2306. 12p.
Autor:
Piccirillo MC; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Chu Q; Cross Cancer Institute, Edmonton, Alberta, Canada., Bradbury P; University Health Network, Toronto, Ontario, Canada., Tu W; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Coschi CH; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Grosso F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., Florescu M; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Mencoboni M; Oncology Unit ASL 3, Villa Scassi Hospital, Genova, Italy., Goffin JR; Juravinski Cancer Centre, Ontario, Canada., Pagano M; Medical Oncology, Comprehensive Cancer Centre, AUSL Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of Reggio Emilia, Reggio Emilia, Italy., Ciardiello F; Oncology and Hematology Unit, University of Campania 'Luigi Vanvitelli,' Naples, Italy., Cecere FL; Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituti Fisioterapici Ospitalieri (IFO) Istituto Regina Elena, Rome, Italy., Vincent M; London Regional Cancer Program, London, Ontario, Canada., Ferrara R; Thoracic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milano, Italy., Dawe DE; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada., Hao D; Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada., Lee CW; British Columbia Cancer Agency, Surrey, British Columbia, Canada., Morabito A; Thoracic Oncology Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy., Gridelli C; Oncology Unit, S. Giuseppe Moscati Hospital, Avellino, Italy., Cavanna L; Oncology and Hematology Department, USL Piacenza, Guglielmo da Saliceto Hospital, Piacenza, Italy., Iqbal M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Blais N; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Leighl NB; University Health Network, Toronto, Ontario, Canada., Wheatley-Price P; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Tsao MS; University Health Network, Toronto, Ontario, Canada., Ugo F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., El-Osta H; Merck & Co, Inc., Rahway, New Jersey., Gargiulo P; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Gaudreau PO; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Tu D; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Sederias J; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Brown-Walker P; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Seymour L; Canadian Cancer Trials Group, Kingston, Ontario, Canada. Electronic address: lseymour@ctg.queensu.ca., Laurie SA; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Jun; Vol. 18 (6), pp. 813-819. Date of Electronic Publication: 2023 Feb 24.
Autor:
Ellis PM; Juravinski Cancer Centre, Hamilton, ON, Canada. Electronic address: Peter.Ellis@jcc.hhsc.ca., Shepherd FA; Princess Margaret Cancer Centre, Toronto, ON, Canada., Millward M; University of Western Australia, Perth, WA, Australia; Australasian Lung Cancer Trials Group, Sydney, NSW, Australia., Perrone F; Clinical Trials Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori-Fondazione G Pascale IRCCS, Napoli, Italy., Seymour L; NCIC Clinical Trials Group, Queen's University, ON, Canada., Liu G; Princess Margaret Cancer Centre, Toronto, ON, Canada., Sun S; British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada., Cho BC; Yonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea., Morabito A; Thoraco-Pulmonary Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale'-IRCCS, Napoli, Italy., Leighl NB; Princess Margaret Cancer Centre, Toronto, ON, Canada., Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Lee CW; British Columbia Cancer Agency, Fraser Valley Centre, Surrey, BC, Canada., Wierzbicki R; R S MacLaughlin Durham RegionalCancer Centre, Oshawa, ON, Canada., Cohen V; Jewish General Hospital and Segal Cancer Centre, McGill University, Montreal, QC, Canada., Blais N; Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Sangha RS; Cross Cancer Institute, Edmonton, AB, Canada., Favaretto AG; Istituto Oncologico Veneto, Padua, Italy., Kang JH; Seoul St Mary's Hospital, The Catholic University, Seoul, South Korea., Tsao MS; Princess Margaret Cancer Centre, Toronto, ON, Canada., Wilson CF; NCIC Clinical Trials Group, Queen's University, ON, Canada., Goldberg Z; Pfizer Oncology, La Jolla, CA, USA., Ding K; NCIC Clinical Trials Group, Queen's University, ON, Canada., Goss GD; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Bradbury PA; NCIC Clinical Trials Group, Queen's University, ON, Canada.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2014 Nov; Vol. 15 (12), pp. 1379-88. Date of Electronic Publication: 2014 Oct 15.